SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,388,330 | -3.7% | 93,329 | -14.1% | 0.02% | -12.0% |
| Q1 2023 | $4,557,779 | +3.3% | 108,622 | -6.1% | 0.02% | 0.0% |
| Q4 2022 | $4,411,463 | +90.3% | 115,665 | +95.4% | 0.02% | +66.7% |
| Q3 2022 | $2,318,000 | +33.8% | 59,183 | +10.3% | 0.02% | +36.4% |
| Q2 2022 | $1,733,000 | +23.2% | 53,643 | +26.2% | 0.01% | +57.1% |
| Q1 2022 | $1,407,000 | -54.9% | 42,503 | -42.1% | 0.01% | -53.3% |
| Q4 2021 | $3,121,000 | +30.9% | 73,377 | +36.3% | 0.02% | +25.0% |
| Q3 2021 | $2,385,000 | +200.8% | 53,833 | +408.1% | 0.01% | +200.0% |
| Q1 2021 | $793,000 | +95.3% | 10,596 | +125.8% | 0.00% | +100.0% |
| Q4 2020 | $406,000 | – | 4,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |